Inventor profile of:

Robert T Foster

City:

Edmonton

Country:

Canada

Published Applications:

37

Last publication date:

2025-11-27

Top Assignees for applications by Robert T Foster

The entities that hold a legal rights for patent applications filed by inventor Foster Robert T:

Recent patent applications by Foster Robert T

Robert T Foster from Edmonton, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-11-27
US20250360181A1
Human necessities

USE OF CYCLOSPORINE ANALOGUES FOR TREATING FIBROSIS

#2 | 2022-06-02
US20220168385A1
Human necessities

USE OF CYCLOSPORINE ANALOGUES AS ANTITHROMBOTIC AGENTS

#3 | 2021-09-02
US20210269479A1
Chemistry; metallurgy

USE OF CYCLOSPORINE ANALOGUES FOR TREATING CANCER

#4 | 2021-08-26
US20210260153A1
Human necessities

USE OF CYCLOSPORINE ANALOGUES FOR TREATING FIBROSIS

#5 | 2017-12-21
US20170362277A1
Chemistry; metallurgy

Cyclosporine analogue mixtures and their use as immunomodulating agents

#6 | 2016-03-17
US20160075741A1
Chemistry; metallurgy

Cyclosporine analogue mixtures and their use as immunomodulating agents

#7 | 2014-12-18
US20140370082A1
Chemistry; metallurgy

CYCLOSPORINE ANALOGUE MIXTURES AND THEIR USE AS IMMUNOMODULATING AGENTS

#8 | 2014-09-25
US20140288266A1
Chemistry; metallurgy

Synthesis of Cyclosporin Analogs

#9 | 2014-09-04
US20140249092A1
Human necessities

CYCLOSPORIN ANALOG FORMULATIONS

#10 | 2014-08-21
US20140235819A1
Chemistry; metallurgy

Deuterated Cyclosporine Analogs and Methods of Making the Same

#11 | 2014-05-22
US20140142277A1
Chemistry; metallurgy

CYCLOSPORINE ANALOGUE MIXTURES AND THEIR USE AS IMMUNOMODULATING AGENTS

#12 | 2013-03-28
US20130078280A1
Human necessities

CYCLOSPORINE ANALOGUE MIXTURES AND THEIR USE AS IMMUNOMODULATING AGENTS

#13 | 2012-08-23
US20120214745A1
Chemistry; metallurgy

Deuterated Cyclosporine Analogs and Methods of Making the Same

#14 | 2011-07-07
US20110166080A1
Chemistry; metallurgy

DEUTERATED CYCLOSPORINE ANALOGS AND METHODS OF MAKING THE SAME

#15 | 2011-06-09
US20110136744A1
Human necessities

CYCLOSPORIN ANALOG FORMULATIONS

#16 | 2011-04-21
US20110092669A1
Chemistry; metallurgy

SYNTHESIS OF CYCLOSPORIN ANALOGS

#17 | 2010-12-09
US20100311944A1
Chemistry; metallurgy

CYCLOSPORINE ANALOGUE MIXTURES AND THEIR USE AS IMMUNOMODULATING AGENTS

#18 | 2010-03-11
US20100062976A1
Chemistry; metallurgy

Synthesis of Cyclosporin Analogs

#19 | 2009-12-24
US20090318336A1
Chemistry; metallurgy

Deuterated Cyclosporine Analogs and Methods of Making the Same

#20 | 2009-02-26
US20090054311A1
Human necessities

Cyclosporin analog formulations

#21 | 2008-07-17
US20080171850A1
Chemistry; metallurgy

Cyclosporine Analogue Mixtures and their Use as Immunomodulating Agents

#22 | 2007-05-03
US20070099848A1
Human necessities

Rapamycin carbohydrate derivatives

#23 | 2007-01-09
US10845747
-

Rapamycin carbohydrate derivatives

#24 | 2006-11-28
US10274437
-

Synthesis of cyclosporin analogs

#25 | 2006-10-05
US20060223743A1
Human necessities

Metabolites of cyclosporin analogs

#26 | 2006-09-28
US20060217309A1
Human necessities

Cyclosporin analog formulations

#27 | 2006-06-22
US20060135414A1
Chemistry; metallurgy

Deuterated cyclosporine analogs and methods of making the same

#28 | 2006-06-13
US10274419
-

Cyclosporin analog formulations

#29 | 2006-04-13
US20060079466A1
Human necessities

Rapamycin carbohydrate derivatives

#30 | 2006-03-09
US20060052290A1
Chemistry; metallurgy

Methods of making deuterated cyclosporin analogs

#31 | 2006-02-14
US10274255
-

Cyclosporine analogue mixtures and their use as immunomodulating agents

#32 | 2005-09-06
US10754488
-

Deuterated rapamycin compounds, method and uses thereof

#33 | 2005-09-01
US20050192214A1
Chemistry; metallurgy

Cyclosporine analogue mixtures and their use as immunomodulating agents

#34 | 2005-08-11
US20050176628A1
Chemistry; metallurgy

Deuterated cyclosporin analogs and their use as immunomodulating agents

#35 | 2005-07-07
US20050147560A1
Human necessities

13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control

#36 | 2005-04-26
US10301504
-

Medical devices incorporating deuterated rapamycin for controlled delivery thereof

#37 | 2005-04-12
US10439290
-

13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control

InventorID:

165220 ⎘